1. Assessment of incidence and trends in cerebrovascular disease in the healthcare district of Lleida (Spain) in the period 2010–2014
- Author
-
J Molina, R. Piñol, X. Cabré, Francisco Purroy, and A.B. Vena
- Subjects
Male ,Population ageing ,Population ,Brain Ischemia ,Health care ,Materials Chemistry ,Humans ,Medicine ,Prospective Studies ,education ,Prospective cohort study ,Stroke ,education.field_of_study ,business.industry ,Incidence ,Incidence (epidemiology) ,Emergency department ,medicine.disease ,Confidence interval ,Cerebrovascular Disorders ,Spain ,Female ,business ,Delivery of Health Care ,Demography - Abstract
Objectives This study aimed to determine the incidence and trends of cerebrovascular disease (CVD) in the healthcare district of Lleida. Material and methods We performed a population-based prospective cohort study including the entire population of the healthcare district of Lleida (440 000 people). Information was gathered from the minimum basic data set from the emergency department and hospital discharges for the period from January 2010 to December 2014. All types of stroke were included. We evaluated crude and age-standardised rates using the world population as a reference. Patients without neuroimaging confirmation of the diagnosis were excluded. Results We identified 4397 patients: 1617 (36.8%) were aged 80 years or over; 3969 (90.3%) presented ischaemic stroke, and 1741 (39.6%) were women. The crude incidence rate ranged from 192 (95% confidence interval [CI], 179-205) to 211 (95% CI, 197-224) cases per 100 000 population, in 2012 and 2013, respectively. Age-standardised rates ranged from 93 (95% CI, 86-100) to 104 (95% CI, 96-111) cases per 100 000 population, in 2012 and 2013, respectively. For all years, incidence rates increased with age, and were significantly higher among men than among women. Conclusion The impact of CVD in Lleida is comparable to that observed in other European regions. However, population ageing induces a high crude incidence rate, which remained stable over the five-year study period.
- Published
- 2022